Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kidney transplant sedative under the microscope

NCT ID NCT07045467

First seen Nov 01, 2025 · Last updated Jun 09, 2026 · Updated 38 times

Summary

This study looks at how the sedative remimazolam behaves in the body of 30 adults receiving a kidney transplant. Researchers will measure drug levels in the blood and monitor sedation depth to ensure safe and predictable anesthesia. The goal is to gather information for better sedation practices in transplant surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shandong First Medical University Hospital

    RECRUITING

    Jinan, Shangdong, 250014, China

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.